Tempest Therapeutics, Inc. Short-Term Debt
Tempest Therapeutics, Inc. (TPST) had Short-Term Debt of $199.00 thousand as of 2019-06-30, per its 10-Q filed 2019-08-12.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current
us-gaap:DebtCurrent · last filed 2019-08-12
- 2019-06-30: Debt, Current $199.00K.
- 2019-03-31: Debt, Current $191.00K.
- 2018-12-31: Debt, Current $189.00K.
- 2017-12-31: Debt, Current $174.00K.
| Period end | Debt, Current |
|---|---|
| 2019-06-30 | $199.00K 10-Q · filed 2019-08-12 |
| 2019-03-31 | $191.00K 10-Q · filed 2019-05-15 |
| 2018-12-31 | $189.00K 10-Q · filed 2019-08-12 |
| 2017-12-31 | $174.00K 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |